1. Need for repeat revascularisation in hybrid coronary revascularisation vs. percutaneous coronary intervention
- Author
-
Łukasz Szymański, Natalia Gołąbek, Jakub Piórek, Witold Gerber, Piotr P. Buszman, and Krzysztof Sanetra
- Subjects
percutaneous coronary intervention ,repeat revascularisation ,hybrid coronary revascularisation ,Medicine - Abstract
Hybrid coronary revascularisation (HCR), being a treatment path combining both coronary artery bypass grafting and percutaneous coronary intervention (PCI) approaches, offers the advantages of both methods in patients with multi-vessel coronary artery disease. Since available literature provides few studies comparing the need for repeat revascularisation (RR) after HCR in comparison to PCI, our review aimed at summarising the latest data on this topic from the last 5 years (2018–2023). The search was conducted within the PubMed and Embase databases, followed by application of inclusion and exclusion criteria and providing a summary of data and characteristics of eligible studies. On the basis of 7 records included in the final analysis, RR and/or follow-up target vessel revascularisation (TVR) were significantly less frequently required in the case of HCR than in PCI in 3 out of 7 records, whereas the remaining four provided no significant differences in analysed rates between the 2 therapeutic pathways. When it comes to lowering the necessity for follow-up TVR and/or RR in a fraction of instances, HCR demonstrates a significant advantage over PCI. The complexity of outcomes associated with these therapies is emphasised by the fact that no statistically significant differences were observed between the 2 methods in the remaining 4 records.
- Published
- 2024
- Full Text
- View/download PDF